Questions discussed in this category
Do you prefer to start with nintedanib and then add immunosuppressive agents, or give a trial of immunosuppressive medication first, then add nintedan...
Would you have a different opinion based on whether it is a new therapy or an existing and previously well-tolerated therapy for the patient?
175091944012645175841644217599161361447910788
Papers discussed in this category
BMJ Open, 2019 May 05
Rheumatol Int, 2021 Jan 29
Scientific reports, 2017 Aug 10
N. Engl. J. Med., 2019 May 20
N Engl J Med, 2019 Sep 29
Arthritis Care Res (Hoboken), 2016 Jan
Alimentary pharmacology & therapeutics, 2022 May 20
Arthritis & rheumatology (Hoboken, N.J.), 2015-05
International journal of rheumatic diseases, 2014-02
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG, 2014-04-18
Clinical nuclear medicine, 2016-05
J Investig Med High Impact Case Rep, 2021 Jan-Dec
Clinical therapeutics, 2018 Feb
Current opinion in pulmonary medicine, 2013 Sep